Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Guo, J.H.
Right arrow Articles by Peng, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.H.
Right arrow Articles by Peng, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Construction and Immunogenic Characterization of a Fusion Anti-caries DNA Vaccine against PAc and Glucosyltransferase I of Streptococcus mutans

J.H. Guo{dagger}, R. Jia{dagger}, M.W. Fan*, Z. Bian, Z. Chen and B. Peng

Key Lab. for Oral Biomedical Engineering of Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, PR China;


Figure 1
View larger version (29K):
[in this window]
[in a new window]

 
Figure 1. Construction and verification of plasmid pGLUA-P. (A) The GLU region of GTF-I of S. mutans was cloned into the eukaryotic expression plasmid pCIA-P to obtain the recombinant plasmid pGLUA-P. (B) Restriction enzyme digestion of pGLUA-P and pCI. pGLUA-P, A-P fragment, GLU fragment, and pCI were measured as 7.1 kb, 2.2 kb, 0.9 kb, and 4.0 kb, respectively. Lane 1: GeneRuler 1 kb DNA ladder. Lane 2: pGLUA-P digested by SmaI. Lane 3: pCI digested by SalI. Lane 4: pGLUA-P digested by SalI and XhoI. Lane 5: pGLUA-P digested by SalI. Lane 6: {gamma}DNA/HindIII marker.

 

Figure 2
Figure 2
Figure 2
Figure 2
View larger version (339K):
[in this window]
[in a new window]

 
Figure 2. Recombinant fusion protein could be expressed in eukaryotic cells. (A) Recombinant fusion protein detected by anti-GTF antibody in the cytoplasm of CHO cells transfected with pGLUA-P. (B) Recombinant fusion protein detected by anti-PAc antibody in the cytoplasm of CHO cells transfected with pGLUA-P. (C) CHO cells transfected with pCIA-P, detected by anti-PAc antibody. (D) CHO cells transfected with pCI vector. Bar, 5 µm.

 

Figure 3
View larger version (20K):
[in this window]
[in a new window]

 
Figure 3 Antibody levels and caries scores of rats immunized with various treatments. Data are expressed as means ± standard deviation. Groups of rats were immunized with plasmids as follows: intramuscular injection of pGLUA-P (GLUA-P/i.m.); subcutaneous injection near the submandibular gland of pGLUA-P (GLUA-P/s.c.); intramuscular injection of pCIA-P (A-P/i.m.); subcutaneous injection of pCIA-P (A-P/s.c.) near the submandibular gland; and intramuscular injection of pCI (control). *Significantly different from the control group at p < 0.01; **significantly different from the control and pCIA-P groups at p < 0.01; #significantly different from DNA-vaccine-immunized group via i.m. at p < 0.01; ^significantly different from DNA-vaccine-immunized group via s.c. at p < 0.05; and +significantly different from pCIA-P immunized group via s.c. at p < 0.05. (A) Saliva- and serum-specific anti-PAc antibody levels (five rats per group). {blacksquare} Serum anti-PAc IgG; {diamondsuit} salivary anti-PAc IgA. (B) Saliva- and serum-specific anti-GTF antibody levels (five rats per group). • Serum anti-GTF IgG; {blacktriangleup} salivary anti-GTF IgA. (C) Keyes caries scores (five rats per group). • Enamel lesion; {blacksquare} slight dentinal lesion; {diamondsuit} moderate dentinal lesion.

 

Journal of Dental Research, Vol. 83, No. 3, 266-270 (2004)
DOI: 10.1177/154405910408300316


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?